Resveratrol Improves Cognitive Impairment by Regulating Apoptosis and Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats

Cellular Physiology and Biochemistry

Volumn 40, Issue 6, 2016, Pages 1670-1677

  Tian, Zhiyan ^a   Wang, Jinhua ^a   Xu, Ming ^b,c   Wang, Yan ^a   Zhang, Miao ^a   Zhou, Yuying ^a  

^a TIANJIN HUANHU HOSPITAL   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Key Laboratory of Stomatology   (China)

Author keywords

Apoptosis; Cognitive impairment; Diabetic rats; Resveratrol; Synaptic plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; GLUCOSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN BAX; PROTEIN BCL 2; RESVERATROL; GLUCOSE BLOOD LEVEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NMDA RECEPTOR A1; STILBENE DERIVATIVE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONOPHARMACOLOGY; COGNITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL AMNESIA; EXPERIMENTAL COGNITIVE DEFECT; GLUCOSE BLOOD LEVEL; LEARNING; LEARNING DISORDER; MALE; MEMORY; MORRIS WATER MAZE TEST; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; COGNITION DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; DRUG EFFECTS; MAZE TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD GLUCOSE; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; COGNITION DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; NEURONAL PLASTICITY; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STILBENES; STREPTOZOCIN; UP-REGULATION;

EID: 85008705007     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000453216     Document Type: Article

References (26)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-20
2. Feldman EL: Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003;111:431-433
3. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV, Yoldas T: Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci 2003;73:1907-1916
4. Sheen YJ, Sheu WH: Association between hypoglycemia and dementia in patients with type 2 diabetes. Diabetes Res Clin Pract 2016;116:279-287
5. Areosa SA, Grimley EV: Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev DOI:10.1002/14651858.cd003804CD003804
6. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-149
7. Nie P, Hu W, Zhang T, Yang Y, Hou B, Zou Z: Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. Cell Physiol Biochem 2015;35:2255-2271
8. Hung LM, Su MJ, Chen JK: Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 2004;36:774-781
9. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E: Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 2007;32:981-987
10. Lin Y, Zhu J, Zhang X, Wang J, Xiao W, Li B, Jin L, Lian J, Zhou L, Liu J: Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress. Cell Physiol Biochem 2016;39:780-789
11. Yin K, Zhao L, Feng D, Ma W, Liu Y, Wang Y, Liang J, Yang F, Bi C, Chen H, Li X, Lu Y, Cai B: Resveratrol Attenuated Low Ambient Temperature-Induced Myocardial Hypertrophy via Inhibiting Cardiomyocyte Apoptosis. Cell Physiol Biochem 2015;35:2451-2462
12. Wang R, Liu YY, Liu XY, Jia SW, Zhao J, Cui D, Wang L: Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model. Cell Physiol Biochem 2014;34:854-864
13. Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Correa M, da Rosa MM, Rubin MA, Chitolina Schetinger MR, Morsch VM: Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009;610:42-48
14. Tiwari V, Chopra K: Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Neurochem Int 2013;62:861-869
15. Zhang J, Liu Z, Li Z, Wang Y, Chen Y, Li X, Chen K, Shu N, Zhang Z: Disrupted White Matter Network and Cognitive Decline in Type 2 Diabetes Patients. J Alzheimers Dis 2016;53:185-195
16. Glodzik L, Randall C, Rusinek H, de Leon MJ: Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. J Alzheimers Dis 2013;35:427-440
17. Wong RH, Nealon RS, Scholey A, Howe PR: Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2016;26:393-399
18. Kennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, Haskell CF: Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 2010;91:1590-1597
19. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316
20. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998;281:1305-1308
21. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-620
22. Zhang J, Li Y, Xu J, Yang Z: The role of N-methyl-D-aspartate receptor in Alzheimer's disease. J Neurol Sci 2014;339:123-129
23. Foster TC, Kyritsopoulos C, Kumar A: Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease. Behav Brain Res DOI:10.1016/j.bbr.2016.05.012
24. Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G: Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci U S A 2009;106:4906-4911
25. Hang P, Sun C, Guo J, Zhao J, Du Z: BDNF-mediates Down-regulation of MicroRNA-195 Inhibits Ischemic Cardiac Apoptosis in Rats. Int J Biol Sci 2016;12:979-989
26. Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang J, Jiang X: More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer Res 2011;30:97